Finally, we examined the capacity of metformin, a widely used anti‐diabetic drug and an emerging anti‐cancer drug, especially in the field of urologic oncology,31, 32, 33 to inhibit the EMT‐based metastatic phenotype, through control of Glo1 and miR‐101 in both PCa cell lines. Here, GLO1 is linked to cancer.